© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
December 01, 2016
Expansion of precision medicine approaches will play a key role in optimizing care and improving outcomes for breast cancer patients in 2017. Here we highlight some of the studies and FDA approvals we are most anxious to see in the coming year.